Skip to main content
Testing version — LOERadar is in active testing. Features and data may change.
LOERadar
LOE
Radar
Hub
News
Changes
Search
Log in
Get Started
WAYRILZ (RILZABRUTINIB) | LOERadar
Viewing data from:
Latest
2026-07-01
2026-06-01
2026-05-01
2026-04-01
2026-03-28
2026-02-17
2026-02-10
2025-12-14
2025-02-26
2025-01-25
2024-11-08
2023-07-23
2023-06-15
2023-05-13
2023-01-26
2022-11-22
2022-10-28
2022-09-29
2022-07-09
2022-06-29
2022-04-08
2022-03-09
2021-12-28
2021-05-05
2021-03-12
2020-12-22
2020-11-12
2019-12-14
2019-09-15
WAYRILZ
NDA
Get alerts
RILZABRUTINIB | N219685 | GENZYME CORP
1 strength
6 unique patents
2 unique exclusivities
Patents
SEC Intel
Revenue
PTAB
Reexams
Litigation
Petitions
Trials
Approvals
Label
Products
Changes
Patent Timeline
6 unique patents, 2 exclusivities by expiration date
Active (6)
Today
Exclusivity
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
Today
8940744
Sep. 6, 2033
9266895
Sep. 6, 2033
9580427
Mar. 1, 2033
9994576
Sep. 6, 2033
11708370
Feb. 20, 2041
12178818
Oct. 13, 2040
NCE
Aug. 29, 2030
ODE-552
Aug. 29, 2032
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
No ANDA patent litigation cases (NOS 835) matched from PACER
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (1)
#001 — 400MG
RLD
6 patents
2 exclusivities
▴
TABLET;ORAL | Approved: Aug 29, 2025
Patents (6)
Patent #
Expiration
PED
Drug Substance
Drug Product
Use Code
Delist
8940744
Sep 6, 2033
—
Yes
Yes
U-4270
METHOD OF TREATMENT OF ADULT PATIENTS WITH PERSISTENT OR CHRONIC IMMUNE THROMBOCYTOPENIA (ITP) WHO HAVE HAD AN INSUFFICIENT RESPONSE TO A PREVIOUS TREATMENT
—
9266895
Sep 6, 2033
—
Yes
Yes
U-4268
METHOD OF INHIBITING BRUTON'S TYROSINE KINASE ACTIVITY IN ADULT PATIENTS WITH PERSISTENT OR CHRONIC IMMUNE THROMBOCYTOPENIA (ITP) WHO HAVE HAD AN INSUFFICIENT RESPONSE TO A PREVIOUS TREATMENT
—
9580427
Mar 1, 2033
—
Yes
Yes
—
—
9994576
Sep 6, 2033
—
Yes
Yes
U-4268
METHOD OF INHIBITING BRUTON'S TYROSINE KINASE ACTIVITY IN ADULT PATIENTS WITH PERSISTENT OR CHRONIC IMMUNE THROMBOCYTOPENIA (ITP) WHO HAVE HAD AN INSUFFICIENT RESPONSE TO A PREVIOUS TREATMENT
—
11708370
Feb 20, 2041
—
Yes
—
—
—
12178818
Oct 13, 2040
—
—
—
U-4267
METHOD FOR TREATING ADULT PATIENTS WITH PERSISTENT OR CHRONIC IMMUNE THROMBOCYTOPENIA (ITP) WHO HAVE HAD AN INSUFFICIENT RESPONSE TO A PREVIOUS TREATMENT, BY ACHIEVING A PLATELET COUNT OF AT LEAST 50,000/UL
—
Exclusivities (2)
Code
Date
Status
NCE
Aug 29, 2030
Active
ODE-552
Aug 29, 2032
Active
Change History (1)
Recent changes detected for this application.
ADDED
7/1/2026
New:
New record